Meeder Asset Management Inc Vir Biotechnology, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $83,512 - $118,072	4,184 Added 245.97%	5,885 $148,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $29,343 - $49,977	1,607 Added 1709.57%	1,701 $33,000
Q2 2022 Aug 08, 2022	BUY	$19.08 - $26.7 $1,793 - $2,509	94 New	94 $2,000
Q4 2020 Feb 09, 2021	SELL	$25.51 - $43.38 $14,285 - $24,292	-560 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$28.28 - $53.6 $12,386 - $23,476	438 Added 359.02%	560 $19,000
Q2 2020 Aug 11, 2020	BUY	$27.89 - $47.86 $3,402 - $5,838	122 New	122 $5,000

231

90.1M

1.28M

235K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.27B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.